- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
Cost-effectiveness of Prostate Health Index for prostate cancer detection - Abstract
December 8, 2011
Role and expression of FRS2 and FRS3 in prostate cancer - Abstract
December 8, 2011
Association of prostate cancer risk alleles with unfavourable pathological characteristics in potential candidates for active surveillance - Abstract
December 8, 2011
Surgical therapy for intermediate risk prostate cancer - Abstract
December 8, 2011
Quality of life after hypofractionated concomitant intensity-modulated radiotherapy boost for high-risk prostate cancer - Abstract
December 8, 2011
Beta-carotene antioxidant use during radiation therapy and prostate cancer outcome in the physicians' health study - Abstract
December 8, 2011
Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostate biopsies - Abstract
December 7, 2011
Transrectal ultrasonography-guided biopsy does not reliably identify dominant cancer location in men with low-risk prostate cancer - Abstract
December 7, 2011
Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer - Abstract
December 7, 2011
Androgen deprivation and thromboembolic events in men with prostate cancer - Abstract
December 6, 2011
Docetaxel-based chemotherapy for hormone-refractory prostate cancer in Japanese patients : Experience in a single institute - Abstract
December 6, 2011
Bone mineral density, pathological fractures and bisphosphonate therapy in prostate cancer patients on androgen deprivation therapy - Abstract
December 6, 2011
Lycopene for the prevention of prostate cancer - Abstract
December 5, 2011